GlobeNewsWire
24 Sept 2026, 05:00 UTC · 4h ago
Verdict
Headline takes no side. We score INDV +0.20 across one claim — slightly bullish.
+0.20slightly bullish
More positive than 53% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
Addex Therapeutics will report 2026 Half-Year and Second Quarter financial results on September 28, 2026.
Newpress release dated September 24, 2026
So whatThe call on the 28th will likely provide the first update on cash runway and burn rates since the previous half-year period.
More positive than 51% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 53% of ticker scores this week
Mention of successful completion of IND enabling studies for a drug candidate developed in partnership with Addex.
Near neutral — 92% of ticker scores this week are stronger
The article is a neutral announcement regarding the scheduling of financial results and a corporate update.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
9h ago
Seeking Alpha
1h ago
—
INDV hasn't traded since this ran. Last close $35.91 (Sep 23); the reaction starts at the next open.
INDV chart →
